Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment
Author(s) -
D. P. Devanand,
Xinhua Liu,
Richard Chunga,
Hannah Cohen,
Howard Andrews,
Peter W. Schofield,
Yaakov Stern,
Edward D. Huey,
Jong-Woo Choi,
Gregory H. Pelton
Publication year - 2020
Publication title -
journal of alzheimer s disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.677
H-Index - 139
eISSN - 1875-8908
pISSN - 1387-2877
DOI - 10.3233/jad-200021
Subject(s) - cognitive impairment , cholinesterase , identification (biology) , cognition , medicine , psychology , pharmacology , psychiatry , biology , botany
Anticholinergic challenge can induce odor identification impairment that indicates Alzheimer's disease (AD) pathology, and short-term change in odor identification impairment with cholinesterase inhibitor (CheI) treatment may predict longer term cognitive outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom